JP2022513164A5 - - Google Patents
Info
- Publication number
- JP2022513164A5 JP2022513164A5 JP2021531011A JP2021531011A JP2022513164A5 JP 2022513164 A5 JP2022513164 A5 JP 2022513164A5 JP 2021531011 A JP2021531011 A JP 2021531011A JP 2021531011 A JP2021531011 A JP 2021531011A JP 2022513164 A5 JP2022513164 A5 JP 2022513164A5
- Authority
- JP
- Japan
- Prior art keywords
- cell population
- cell
- peripheral blood
- blood mononuclear
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862774142P | 2018-11-30 | 2018-11-30 | |
| US62/774,142 | 2018-11-30 | ||
| US201962878736P | 2019-07-25 | 2019-07-25 | |
| US62/878,736 | 2019-07-25 | ||
| PCT/US2019/064074 WO2020113234A1 (en) | 2018-11-30 | 2019-12-02 | Placenta-derived allogeneic car-t cells and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022513164A JP2022513164A (ja) | 2022-02-07 |
| JP2022513164A5 true JP2022513164A5 (cg-RX-API-DMAC7.html) | 2022-12-19 |
Family
ID=69005946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021531011A Pending JP2022513164A (ja) | 2018-11-30 | 2019-12-02 | 胎盤由来同種car-t細胞およびその使用 |
Country Status (13)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4069258A1 (en) * | 2019-12-04 | 2022-10-12 | Celularity Inc. | Placenta-derived allogeneic car-t cells and uses thereof |
| CA3186065A1 (en) * | 2020-07-16 | 2022-01-20 | Xiaohu FAN | Cd19 binding molecules and uses thereof |
| JP7846667B2 (ja) | 2020-07-16 | 2026-04-15 | レジェンド バイオテック アイルランド リミテッド | Cd20結合分子及びその使用 |
| CN122003245A (zh) * | 2023-07-10 | 2026-05-08 | 普拉里生物科技有限公司 | 用于过继转移细胞疗法的基因工程化黏膜相关恒定t (mait)细胞 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3614866B2 (ja) | 1997-06-12 | 2005-01-26 | リサーチ コーポレイション テクノロジーズ,インコーポレイティド | 人工抗体ポリペプチド |
| CA3103505C (en) * | 2006-05-11 | 2023-07-04 | Celularity Inc. | Methods for collecting and using placenta cord blood stem cells |
| EP2997134B1 (en) * | 2013-05-14 | 2020-06-24 | Board of Regents, The University of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| CN105916521A (zh) * | 2013-11-15 | 2016-08-31 | 人类起源公司 | 包含人胎盘灌注液细胞、其亚群的组合物及其用途 |
| SG10201808811QA (en) * | 2014-04-10 | 2018-11-29 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Method and compositions for cellular immunotherapy |
| AU2015317316A1 (en) * | 2014-09-19 | 2017-04-06 | City Of Hope | Central memory T cells for adoptive T cell therapy |
| US10201606B2 (en) * | 2014-11-26 | 2019-02-12 | Miltenyi Biotec Gmbh | Combination immunotherapy of antigen-recognizing receptors and hematopoietic cells for the treatment of diseases |
| US10383929B2 (en) * | 2014-12-12 | 2019-08-20 | Bluebird Bio, Inc. | BCMA chimeric antigen receptors |
| HK1246180A1 (zh) * | 2014-12-31 | 2018-09-07 | Celgene Corporation | 使用自然杀伤细胞治疗血液病症、实体瘤或感染性疾病的方法 |
| US20160228547A1 (en) * | 2015-02-06 | 2016-08-11 | Batu Biologics, Inc. | Chimeric antigen receptor targeting of tumor endothelium |
| US20160237407A1 (en) * | 2015-02-17 | 2016-08-18 | Batu Biologics, Inc. | Universal donor chimeric antigen receptor cells |
| WO2016168595A1 (en) * | 2015-04-17 | 2016-10-20 | Barrett David Maxwell | Methods for improving the efficacy and expansion of chimeric antigen receptor-expressing cells |
| NZ737556A (en) * | 2015-05-26 | 2022-11-25 | Celularity Inc | Angiogenesis using stimulated placental stem cells |
| US10829735B2 (en) * | 2015-07-21 | 2020-11-10 | The Trustees Of The University Of Pennsylvania | Methods for improving the efficacy and expansion of immune cells |
| CA2999070A1 (en) * | 2015-09-17 | 2017-03-23 | Novartis Ag | Car t cell therapies with enhanced efficacy |
| CN105331585A (zh) * | 2015-11-13 | 2016-02-17 | 科济生物医药(上海)有限公司 | 携带pd-l1阻断剂的嵌合抗原受体修饰的免疫效应细胞 |
| CN109072194B (zh) * | 2015-12-09 | 2022-12-27 | 纪念斯隆-凯特林癌症中心 | 免疫细胞组合物及其使用方法 |
| US20200087681A1 (en) * | 2016-12-21 | 2020-03-19 | Ucl Business Plc | Therapeutic cells |
-
2019
- 2019-12-02 AU AU2019387571A patent/AU2019387571A1/en not_active Abandoned
- 2019-12-02 CN CN201980078364.2A patent/CN113395972A/zh active Pending
- 2019-12-02 MX MX2021006402A patent/MX2021006402A/es unknown
- 2019-12-02 US US17/309,451 patent/US20220118014A1/en active Pending
- 2019-12-02 WO PCT/US2019/064074 patent/WO2020113234A1/en not_active Ceased
- 2019-12-02 KR KR1020217016359A patent/KR20210111244A/ko not_active Ceased
- 2019-12-02 SG SG11202105217RA patent/SG11202105217RA/en unknown
- 2019-12-02 EP EP19828010.9A patent/EP3886876A1/en not_active Withdrawn
- 2019-12-02 BR BR112021010132-2A patent/BR112021010132A2/pt not_active IP Right Cessation
- 2019-12-02 CA CA3120364A patent/CA3120364A1/en active Pending
- 2019-12-02 JP JP2021531011A patent/JP2022513164A/ja active Pending
-
2021
- 2021-05-13 ZA ZA2021/03263A patent/ZA202103263B/en unknown
- 2021-05-28 PH PH12021551246A patent/PH12021551246A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wu et al. | CD3+ CD4-CD8-(double-negative) T cells in inflammation, immune disorders and cancer | |
| Li et al. | Engineering allorejection-resistant CAR-NKT cells from hematopoietic stem cells for off-the-shelf cancer immunotherapy | |
| Leung | Use of NK cell activity in cure by transplant | |
| Gattinoni et al. | T memory stem cells in health and disease | |
| Mehta et al. | Cord blood as a source of natural killer cells | |
| Seliger et al. | Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies | |
| US20210228632A1 (en) | Compostion for use in immunotherapy | |
| Zeng et al. | Type 1 regulatory T cells: a new mechanism of peripheral immune tolerance | |
| Cerwenka et al. | Natural killer cell memory in infection, inflammation and cancer | |
| Ni et al. | Sustained effector function of IL-12/15/18–preactivated NK cells against established tumors | |
| Amrolia et al. | Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation | |
| Oevermann et al. | Immune reconstitution and strategies for rebuilding the immune system after haploidentical stem cell transplantation | |
| Berger et al. | Adoptive transfer of virus-specific and tumor-specific T cell immunity | |
| WO2012156958A4 (en) | Cell line of lymphocytes comprising gamma-delta t cells, composition and production method thereof | |
| Kroesen et al. | A transplantable TH‐MYCN transgenic tumor model in C57Bl/6 mice for preclinical immunological studies in neuroblastoma | |
| JP5118624B2 (ja) | 新規なヒトt細胞集団 | |
| JP2016539929A5 (cg-RX-API-DMAC7.html) | ||
| Babor et al. | The role of KIR genes and ligands in leukemia surveillance | |
| Kwak et al. | Insights into myeloid-derived suppressor cells in inflammatory diseases | |
| Parisi et al. | The more, the better:“do the right thing” for natural killer immunotherapy in acute myeloid leukemia | |
| Biondi et al. | Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia | |
| Choi et al. | The function of memory CD8+ T cells in immunotherapy for human diseases | |
| Valencic et al. | The immunosuppressive effect of Wharton's jelly stromal cells depends on the timing of their licensing and on lymphocyte activation | |
| Damele et al. | Targeted therapies: friends or foes for patient’s NK cell-mediated tumor immune-surveillance? | |
| JP2013536232A5 (cg-RX-API-DMAC7.html) |